Last reviewed · How we verify
NCT03459066
Predictors Factors and Time of Onset of Spasticity and Their Relationship With the Functionality and Quality of Life.
trial testing Institution-Group in Post Stroke Spasticity in 100 participants. Completed in 30 October 2020.
30 March 2019
Quick facts
| Lead sponsor | Universidad de La Frontera |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 October 2018 |
| Primary completion | 30 March 2019 |
| Estimated completion | 30 October 2020 |
| Sites | 1 location across Chile |
Drugs / interventions tested
- Institution-Group
Conditions studied
- Post Stroke Spasticity — all drugs for Post Stroke Spasticity →
Sponsor
Universidad de La Frontera — full company profile →
Who can join
Adults 20 to 80, any sex, with Post Stroke Spasticity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Spasticity is part of the syndrome motor neuron following a Stroke. It is a clinical sign of great complexity that generates disability, limiting the function and altering the quality of life of the subjects, generating great impact on families and society. Identify times and characteristics of appearance; as well as its predictive factors can support an early intervention, orienting and strengthening the work of the rehabilitation team. Determine the times of establishment, location and factors that favor the development of spasticity in acute stage and how it influences the functionality, quality of life and emotional level of post-stroke patients in hospital facilities. Through this proposal, it is proposed to generate a new line of research that allows the development of scientific evidence in the area of neurorehabilitation, specifically in the field of spasticity, through the identification of establishment times, affected structures and predominant patterns in the extremities; as well as determining factors that favor the development of spasticity and its impact on post-stroke functionality and quality of life. This information will strengthen the rehabilitative process of these subjects and the actions of the rehabilitation team, supporting the identification of preventive measures and implementing effective interventions that allow achieving better motor and functional results, in search of an optimal recovery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03459066
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post Stroke Spasticity
Currently open trials in the same condition.
- NCT07190092 — Deep Anterior Cerebellar Stimulation in Treatment of Poststroke Spasticity and Motor Function Impairment. · NA · recruiting
Other Universidad de La Frontera trials
Trials by the same sponsor.
- NCT06786975 — Effectiveness and Acceptability of SDF Compared to ART for the Management of Early Childhood Caries · NA · not yet recruiting
- NCT07152197 — Effects of Resistance Exercises in Hereditary Sensory-Motor Neuropathy (Charcot-Marie-Tooth Disease) · NA · recruiting
- NCT06974071 — Effectiveness of Nonpharmacologic Therapies on Pain After Removal of Chest Drains in Postoperative Cardiac Surgery · NA · active not recruiting
- NCT06469346 — Comparison of Eccentric Exercise and Static Stretching on Muscle Flexibility · NA · active not recruiting
- NCT07156760 — Morphological Characteristics of the Upper and Lower Extremities Using Ultrasound Examination After Stroke. · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03459066 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad de La Frontera
- Last refreshed: 3 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03459066.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing